238 related articles for article (PubMed ID: 12376401)
1. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement.
Wu MF; John J; Maidment N; Lam HA; Siegel JM
Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1079-86. PubMed ID: 12376401
[TBL] [Abstract][Full Text] [Related]
2. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
3. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
[TBL] [Abstract][Full Text] [Related]
4. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
[TBL] [Abstract][Full Text] [Related]
5. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.
Wu MF; Nienhuis R; Maidment N; Lam HA; Siegel JM
J Neurosci; 2011 Apr; 31(17):6305-10. PubMed ID: 21525270
[TBL] [Abstract][Full Text] [Related]
6. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation.
Pedrazzoli M; D'Almeida V; Martins PJ; Machado RB; Ling L; Nishino S; Tufik S; Mignot E
Brain Res; 2004 Jan; 995(1):1-6. PubMed ID: 14644464
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin (orexin): role in normal behavior and neuropathology.
Siegel JM
Annu Rev Psychol; 2004; 55():125-48. PubMed ID: 14744212
[TBL] [Abstract][Full Text] [Related]
8. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity.
Martins PJ; D'Almeida V; Pedrazzoli M; Lin L; Mignot E; Tufik S
Regul Pept; 2004 Mar; 117(3):155-8. PubMed ID: 14749034
[TBL] [Abstract][Full Text] [Related]
9. Release of hypocretin (orexin) during waking and sleep states.
Kiyashchenko LI; Mileykovskiy BY; Maidment N; Lam HA; Wu MF; John J; Peever J; Siegel JM
J Neurosci; 2002 Jul; 22(13):5282-6. PubMed ID: 12097478
[TBL] [Abstract][Full Text] [Related]
10. The diurnal rhythm of hypocretin in young and old F344 rats.
Desarnaud F; Murillo-Rodriguez E; Lin L; Xu M; Gerashchenko D; Shiromani SN; Nishino S; Mignot E; Shiromani PJ
Sleep; 2004 Aug; 27(5):851-6. PubMed ID: 15453542
[TBL] [Abstract][Full Text] [Related]
11. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression.
Allard JS; Tizabi Y; Shaffery JP; Manaye K
Neuropeptides; 2007 Oct; 41(5):329-37. PubMed ID: 17590434
[TBL] [Abstract][Full Text] [Related]
12. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of orexins/hypocretins in multiple physiological functions].
Ueta Y
J UOEH; 2001 Jun; 23(2):147-59. PubMed ID: 11431960
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.
John J; Wu MF; Siegel JM
Sleep Res Online; 2000; 3(1):23-8. PubMed ID: 11382896
[TBL] [Abstract][Full Text] [Related]
16. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
[TBL] [Abstract][Full Text] [Related]
17. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
[TBL] [Abstract][Full Text] [Related]
18. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
19. [Positivity analysis of human leukocyte histocompatibility antigen-DQB1*0602 allele in Chinese patients with narcolepsy].
Li J; Dong X; Yan H; Liu Y; An P; Zhao L; Li Q; Zhang X; Gao Z; Han F
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):763-5. PubMed ID: 24844961
[TBL] [Abstract][Full Text] [Related]
20. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness.
Zeitzer JM; Buckmaster CL; Parker KJ; Hauck CM; Lyons DM; Mignot E
J Neurosci; 2003 Apr; 23(8):3555-60. PubMed ID: 12716965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
